NYSE •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization326.22 mln
Float11.27 mln
Earnings Date05/07/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
17.50
Transformational upside
Relative Strength
1
/ 100
Severely lagging
Debt / Equity
-1.32
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Armata Pharmaceuticals is a Los Angeles-based drug development company working on new treatments for dangerous bacterial infections that no longer respond to standard antibiotics. Rather than using conventional antibiotics, the company harnesses bacteriophages ? naturally occurring viruses that can seek out and destroy specific bacteria ? to fight infections caused by organisms such as Staphylococcus aureus and Pseudomonas aeruginosa. Armata works alongside pharmaceutical giant Merck to explore additional applications of this technology and operates as part of the Innoviva group of companies.
